Avivagen: The OxC-beta™ Technology Is A True Game Changer
Featured
2 weeks ago
Avivagen: The OxC-beta™ Technology Is A True Game Changer
Life science stocks are gaining an increasing amount of attention with every passing day as…
Excellent Safety Data For COVID-19 Drug Candidate Plus $15 Million In Cash Put NanoViricides In The Driver’s Seat
Featured
3 weeks ago
Excellent Safety Data For COVID-19 Drug Candidate Plus $15 Million In Cash Put NanoViricides In The Driver’s Seat
Anti-viral research has become one of the biggest priorities of the healthcare industry across the…
Safety and Tolerability of Anti-Coronavirus Drug Candidates Observed in an Animal Model Further Advances NanoViricides’ SARS-CoV-2 Therapeutics Program
Biotech
July 8, 2020
Safety and Tolerability of Anti-Coronavirus Drug Candidates Observed in an Animal Model Further Advances NanoViricides’ SARS-CoV-2 Therapeutics Program
Shelton, Connecticut — July 8, 2020 — NanoViricides, Inc. (NYSE American: NNVC) (the “Company”) a leader…
